Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19203051 | 0.97 | ANPEP (0.34) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19202717 | 0.96 | L3MBTL1 (0.36) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19203005 | 0.94 | ANPEP (0.34) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19203056 | 0.93 | L3MBTL1 (0.38) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19203050 | 0.93 | L3MBTL1 (0.38) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19203053 | 0.93 | ANPEP (0.31) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19203033 | 0.92 | ANPEP (0.34) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL20083810 | 0.92 | L3MBTL1 (0.38) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19202712 | 0.92 | L3MBTL1 (0.38) | ANPEPL3MBTL1ALDH1A1HPGDTSHR | |
| SCHEMBL19203001 | 0.90 | ANPEP (0.34) | ANPEPL3MBTL1ALDH1A1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3312159-B1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO (JP) | 2022-01-26 | — | — | EP | disclosed |
| US-10790449-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-29 | — | — | US | disclosed |
| EP-3312159-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-20170222152-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20170222152-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10790449-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device | RPL19, LEF1, RPL39 | ANPEP 3942/4885L3MBTL1 174/4885ALDH1A1 969/4885 |
| US-20170222152-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | RPL19, LEF1, RPL39 | ANPEP 3942/4885L3MBTL1 174/4885ALDH1A1 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.